These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17038738)

  • 1. ABC of obesity. Management: part II--drugs.
    Lean M; Finer N
    BMJ; 2006 Oct; 333(7572):794-7. PubMed ID: 17038738
    [No Abstract]   [Full Text] [Related]  

  • 2. National trends in the use and costs of anti-obesity medications in England 1998-2005.
    Srishanmuganathan J; Patel H; Car J; Majeed A
    J Public Health (Oxf); 2007 Jun; 29(2):199-202. PubMed ID: 17494061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term drug therapy of obesity in 2002--pharmacoeconomic aspects].
    Minarcíková I
    Ceska Slov Farm; 2003 Sep; 52(5):258-61. PubMed ID: 14619705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comment of J. Fritze: Is therapy of obesity with orlistat medically necessary?].
    Wirth A
    Versicherungsmedizin; 1999 Sep; 51(3):137-8; author reply 138-9. PubMed ID: 10516837
    [No Abstract]   [Full Text] [Related]  

  • 5. Obesity: the fat lady sings?
    Cairns E
    Drug Discov Today; 2005 Mar; 10(5):305-7. PubMed ID: 15749277
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-obesity drugs: use, mechanisms and clinical importance.
    Adam O; Forth W
    Int J Clin Pharmacol Ther; 2001 Jun; 39(6):232-8. PubMed ID: 11430630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use and costs of bariatric surgery and prescription weight-loss medications.
    Encinosa WE; Bernard DM; Steiner CA; Chen CC
    Health Aff (Millwood); 2005; 24(4):1039-46. PubMed ID: 16012144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of orlistat initiation on cardiovascular treatment use: a 6-year population-based cohort study.
    Czernichow S; Knol MJ; Fezeu L; Grobbee DE
    Eur J Prev Cardiol; 2012 Jun; 19(3):484-9. PubMed ID: 21464100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Obesity and health economics. Review and status].
    Pedersen KM; Worre-Jensen AL
    Ugeskr Laeger; 2006 Jan; 168(2):196-201. PubMed ID: 16403351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical interventions for obesity: a public health perspective.
    Caveney E; Caveney BJ; Somaratne R; Turner JR; Gourgiotis L
    Diabetes Obes Metab; 2011 Jun; 13(6):490-7. PubMed ID: 21205125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are newer drugs better drugs?
    Andersen T
    Obes Rev; 2003 May; 4(2):75. PubMed ID: 12760440
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of orlistat for the treatment of overweight and obese patients in Ireland.
    Lacey LA; Wolf A; O'shea D; Erny S; Ruof J
    Int J Obes (Lond); 2005 Aug; 29(8):975-82. PubMed ID: 15852050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy of obesity will come later].
    Falkenberg M
    Lakartidningen; 1999 May; 96(21):2582-3. PubMed ID: 10388276
    [No Abstract]   [Full Text] [Related]  

  • 14. What is the long-term efficacy and tolerability of orlistat, a gastrointestinal lipase inhibitor, for the treatment of obesity in primary care?
    Leiser JP; Gunning K
    J Fam Pract; 2000 Jun; 49(6):572-3. PubMed ID: 10923560
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicare Should Cover Weight Loss Drugs as Long as the Prices are Affordable.
    Hwang CS; Kesselheim AS; Rome BN
    J Law Med Ethics; 2024; 52(1):188-190. PubMed ID: 38818585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orlistat for the treatment of obesity: cost utility model.
    Foxcroft DR
    Obes Rev; 2005 Nov; 6(4):323-8. PubMed ID: 16246217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity market overview.
    Farrigan C; Pang K
    Nat Rev Drug Discov; 2002 Apr; 1(4):257-8. PubMed ID: 12120276
    [No Abstract]   [Full Text] [Related]  

  • 18. Diet-drug dilemma.
    Blackburn G
    Health News; 1999 Jun; 5(7):2. PubMed ID: 10932774
    [No Abstract]   [Full Text] [Related]  

  • 19. New drug targets for the treatment of obesity.
    Powell AG; Apovian CM; Aronne LJ
    Clin Pharmacol Ther; 2011 Jul; 90(1):40-51. PubMed ID: 21654742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmaceutical market for obesity therapies.
    Wong D; Sullivan K; Heap G
    Nat Rev Drug Discov; 2012 Sep; 11(9):669-70. PubMed ID: 22935797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.